A once-monthly GLP-1 receptor agonist for treatment of diabetic cats

艾塞那肽 药理学 药代动力学 医学 兴奋剂 内科学 受体 内分泌学 2型糖尿病 糖尿病
作者
Eric L. Schneider,Ralph Reid,David G. Parkes,Thomas Lutz,Gary W. Ashley,Daniel V. Santi
出处
期刊:Domestic Animal Endocrinology [Elsevier]
卷期号:70: 106373-106373 被引量:8
标识
DOI:10.1016/j.domaniend.2019.07.001
摘要

There is growing evidence that peptidic glucagon-like peptide-1 receptor agonists (GLP-1RA), such as exenatide, may provide useful therapeutic options for treatment of feline diabetes. However, because such drugs are administered subcutaneously, it is desirable that they be long-acting and not require frequent injections. We have developed a chemically controlled delivery system to support half-life extension of peptidic therapeutics. Here, the peptide is covalently attached to hydrogel microspheres by a self-cleaving β-eliminative linker; after subcutaneous injection of the microspheres, the peptide is slowly released from the depot to the systemic circulation. Using this technology, we developed a delivery system that supports once-monthly administration of a stable exenatide analog, [Gln28]exenatide, in rodents (Schneider, et al, ACS Chem Biol 12, 2107 to 2116, 2017). The purposes of the present study were a) to demonstrate pharmacokinetic and pharmacodynamic similarities of the deamidation-sensitive GLP-1RA exenatide and the closely related, more stable [Gln28]exenatide and b) to develop a long-acting GLP-1RA in cats. The results show that exenatide and [Gln28]exenatide injected intravenously or subcutaneously at 10 μg/kg have nearly identical pharmacokinetics in the cat—both having elimination half-lives of ∼40 min—but subcutaneously administered [Gln28]exenatide has superior bioavailability—93% for [Gln28]exenatide vs 52% for exenatide. The results also show that exenatide and [Gln28]exenatide have similar insulinotropic activities in the cat during a high-dose intravenous glucose tolerance test; they increased the area under the curve (AUC) for insulin to a similar extent but had no effect on glucose AUC. Finally, subcutaneous injection of a microsphere-[Gln28]exenatide conjugate containing an appropriate self-cleaving linker in the cat provides plasma [Gln28]exenatide with a half-life of about 40 d vs 40 min with the injected free peptide. Hence, the large body of information available for exenatide can be used to facilitate clinical development of [Gln28]exenatide as a treatment for feline diabetes, and the microsphere-[Gln28]exenatide conjugate is quite suitable for once-monthly subcutaneous administration of the peptide in the cat.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
2秒前
蓝冰完成签到,获得积分10
2秒前
阿北完成签到,获得积分10
4秒前
wcdd发布了新的文献求助10
5秒前
乐乐应助俭朴的红牛采纳,获得10
6秒前
赘婿应助lewisll采纳,获得10
6秒前
6秒前
白菜包子完成签到 ,获得积分10
8秒前
8R60d8应助科研通管家采纳,获得10
8秒前
8秒前
CipherSage应助科研通管家采纳,获得10
8秒前
maox1aoxin应助科研通管家采纳,获得30
8秒前
天天快乐应助科研通管家采纳,获得10
8秒前
无花果应助科研通管家采纳,获得10
8秒前
李爱国应助科研通管家采纳,获得10
8秒前
桐桐应助科研通管家采纳,获得10
8秒前
英姑应助科研通管家采纳,获得10
8秒前
酷炫应助科研通管家采纳,获得10
8秒前
今后应助科研通管家采纳,获得10
8秒前
9秒前
嗯哼应助科研通管家采纳,获得20
9秒前
10秒前
大卫完成签到 ,获得积分10
11秒前
13秒前
葉落葉飄完成签到,获得积分20
13秒前
14秒前
15秒前
kate完成签到,获得积分10
15秒前
orixero应助丶氵一生里采纳,获得10
15秒前
lulu完成签到,获得积分10
15秒前
Aoren完成签到,获得积分10
16秒前
16秒前
孟寐以求完成签到 ,获得积分10
17秒前
18秒前
眯眯眼的问凝完成签到,获得积分20
18秒前
蓼木er发布了新的文献求助10
19秒前
lulu发布了新的文献求助10
20秒前
Aoren发布了新的文献求助10
20秒前
闫伊森完成签到,获得积分10
21秒前
lewisll发布了新的文献求助10
22秒前
高分求助中
Evolution 10000
ISSN 2159-8274 EISSN 2159-8290 1000
Becoming: An Introduction to Jung's Concept of Individuation 600
Ore genesis in the Zambian Copperbelt with particular reference to the northern sector of the Chambishi basin 500
A new species of Coccus (Homoptera: Coccoidea) from Malawi 500
A new species of Velataspis (Hemiptera Coccoidea Diaspididae) from tea in Assam 500
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3161703
求助须知:如何正确求助?哪些是违规求助? 2812994
关于积分的说明 7898049
捐赠科研通 2471906
什么是DOI,文献DOI怎么找? 1316269
科研通“疑难数据库(出版商)”最低求助积分说明 631278
版权声明 602129